Normal view MARC view ISBD view

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis.

Stübig, T

JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis. [electronic resource] - Leukemia Aug 2014 - 1736-8 p. digital

Publication Type: Letter

ISSN: 1476-5551

Standard No.: 10.1038/leu.2014.86 doi

Subjects--Topical Terms:
Adult
Aged
Female
Hematopoietic Stem Cell Transplantation
Humans
Janus Kinases--antagonists & inhibitors
Male
Middle Aged
Nitriles
Primary Myelofibrosis--drug therapy
Pyrazoles--adverse effects
Pyrimidines
Transplantation, Homologous

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)